[
    [
        {
            "time": "",
            "original_text": "睿智医药乱象丛生 盈利能力低下 增速远逊同行",
            "features": {
                "keywords": [
                    "睿智医药",
                    "乱象丛生",
                    "盈利能力低下",
                    "增速远逊同行"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "睿智医药乱象丛生 盈利能力低下 增速远逊同行",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "JP Morgan Chase 增持康龙化成股份约23.67万股",
            "features": {
                "keywords": [
                    "JP Morgan Chase",
                    "增持",
                    "康龙化成",
                    "23.67万股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "JP Morgan Chase 增持康龙化成股份约23.67万股",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "21硬核研报丨CRO淘金赛道“领跌者” 泰格医药转型“投资家”AB面",
            "features": {
                "keywords": [
                    "CRO",
                    "淘金赛道",
                    "领跌者",
                    "泰格医药",
                    "转型",
                    "投资家"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "21硬核研报丨CRO淘金赛道“领跌者” 泰格医药转型“投资家”AB面",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "2021年医药生物中期策略报告：需求长期景气 布局创新、医疗服务和消费主线",
            "features": {
                "keywords": [
                    "2021年",
                    "医药生物",
                    "中期策略",
                    "需求长期景气",
                    "布局创新",
                    "医疗服务",
                    "消费主线"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2021年医药生物中期策略报告：需求长期景气 布局创新、医疗服务和消费主线",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]